| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.96▼ | 12.96▼ | 12.96▼ | 12.94▲ | 14.66▼ |
| MA10 | 12.98▼ | 13.01▼ | 13.06▼ | 13.67▼ | 14.34▼ |
| MA20 | 12.98▼ | 13.09▼ | 13.12▼ | 14.54▼ | 15.20▼ |
| MA50 | 13.00▼ | 13.04▼ | 13.25▼ | 14.27▼ | 18.40▼ |
| MA100 | 13.10▼ | 13.34▼ | 14.24▼ | 15.47▼ | 18.88▼ |
| MA200 | 13.16▼ | 14.38▼ | 14.70▼ | 17.85▼ | 19.34▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.023▼ | -0.005▼ | -0.266▼ | 0.092▲ |
| RSI | 46.300▼ | 42.217▼ | 41.929▼ | 36.776▼ | 38.973▼ |
| STOCH | 33.048 | 16.712▼ | 14.235▼ | 14.221▼ | 56.537 |
| WILL %R | -66.667 | -82.979▼ | -87.500▼ | -83.726▼ | -82.411▼ |
| CCI | -53.567 | -86.516 | -120.266▼ | -82.411 | -97.893 |
|
Thursday, March 13, 2025 01:41 PM
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/03/25 | 13.19 | 13.32 | 12.86 | 12.95 | 767,121 |
| 13/03/25 | 13.18 | 13.53 | 13.00 | 13.10 | 1,548,303 |
| 12/03/25 | 13.13 | 13.48 | 12.96 | 13.12 | 1,462,262 |
| 11/03/25 | 12.37 | 13.13 | 12.26 | 13.00 | 1,702,727 |
| 10/03/25 | 13.19 | 13.40 | 12.39 | 12.53 | 1,873,875 |
| 07/03/25 | 14.20 | 14.39 | 13.24 | 13.42 | 3,422,109 |
| 06/03/25 | 14.37 | 14.565 | 13.86 | 14.29 | 2,468,872 |
| 05/03/25 | 14.29 | 14.6149 | 14.00 | 14.48 | 2,010,238 |
| 04/03/25 | 15.37 | 15.92 | 14.09 | 14.38 | 4,007,452 |
| 03/03/25 | 16.05 | 16.50 | 14.84 | 15.48 | 3,144,772 |
|
|
||||
|
|
||||
|
|